Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
192M
-
Number of holders
-
465
-
Total 13F shares, excl. options
-
178M
-
Shares change
-
+3.78M
-
Total reported value, excl. options
-
$15.2B
-
Value change
-
+$318M
-
Put/Call ratio
-
1.4
-
Number of buys
-
214
-
Number of sells
-
-224
-
Price
-
$85.65
Significant Holders of BIOMARIN PHARMACEUTICAL INC - COM (BMRN) as of Q2 2019
571 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - COM as of Q2 2019.
BIOMARIN PHARMACEUTICAL INC - COM (BMRN) has 465 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 178M shares
of 192M outstanding shares and own 92.68% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (19.7M shares), VANGUARD GROUP INC (16M shares), PRIMECAP MANAGEMENT CO/CA/ (14.3M shares), BlackRock Inc. (12.9M shares), JENNISON ASSOCIATES LLC (9.45M shares), BAKER BROS. ADVISORS LP (7.59M shares), Clearbridge Investments, LLC (5.97M shares), SANDS CAPITAL MANAGEMENT, LLC (5.73M shares), STATE STREET CORP (4.69M shares), and NUVEEN ASSET MANAGEMENT, LLC (3.01M shares).
This table shows the top 465 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.